Izuma Nakayama

30PUBLICATIONS
137CO-AUTHORS
Tumour immunologyMolecular targetsHaematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 07, 2026
Spatial organisation of tumor-infiltrating B-cells informs immune checkpoint inhibitor response in Claudin 18.2-expressing gastric cancer.

|Jun 01, 2026
EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.

|May 21, 2026
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer.

|May 21, 2026
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-Immunotherapy.

|Mar 15, 2026
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.

Takeru Wakatsuki, Noriko Yamamoto, Naoki Ishizuka

|Mar 11, 2026
Bridging paradigms and shaping the future of resectable gastric cancer: a narrative review of the post-MATTERHORN era.

Dai Okemoto, Izuma Nakayama, Kohei Shitara

Pageof 5

Frequent Collaborators

13 joint publications

Kohei Shitara

5 joint publications

Kensei Yamaguchi

5 joint publications

Kazumasa Yamamoto

5 joint publications

Daisuke Takahari